FDA extends DTC guidance comment period
Executive Summary
FDA reopens comment period for draft guidances on direct-to-consumer advertising until Aug. 10. "We got comments that folks wanted more time to do DTC research, complete DTC research and also more time to provide comments," Ad Division Director Tom Abrams said during a DIA audioconference May 27. The agency also plans to conduct its own research on the content and format of the brief summary. FDA released the DTC guidances Feb. 4 (1"The Pink Sheet" Feb. 9, 2004, p. 3)...
You may also be interested in...
FDA Releases DTC Guidances; “Not The Last Word” On Ads, McClellan Says
FDA's publication of three draft guidances on direct-to-consumer advertising is unlikely to relieve pressure on the agency to explain its approach to enforcement actions against drug manufacturers that repeatedly run false and misleading promotions
Sandoz Stands Alone As It Completes Novartis Spinoff
Sandoz has heralded a “new era as a standalone global leader and European champion in generic and biosimilar medicines” after completing its long journey towards independence by separating from former parent company Novartis.
Cell/Gene Therapy Is Ripe For Real-World Data Given Length Of Follow-Up Required, Abernethy Says
The former principal deputy commissioner outlined what she sees as the future data requirements for real world evidence and why cell and gene therapy will lead the way.